Stephen Graziano profile picture
315-464-4353

Stephen Graziano, MD

CURRENT APPOINTMENTS

Professor of Medicine
Division Chief of Hematology and Oncology
Division Chief of Medicine

SPECIALTIES

Internal Medicine
Oncology
Hematology
Medical Oncology

LANGUAGES

English

PATIENT TYPE

Adults

CLINICAL BACKGROUND AND MY APPROACH TO CARE

Lung cancer and Thoracic Malignancies

Prognostic Factors in Patients with Non-Small Cell Lung Cancer; lung cancer clinical trials; participation in the Alliance for Clinical Trials in Oncology. 

CLINICAL TRIALS

A081801-Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Read more
EA5181: Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Read more
A randomized, open-label, phase II study of canakinumab or pembrolizumab as monotherapy or in combination as neoadjuvant therapy in subjects with resectable non-small cell lung cancer (CANOPY-N)
Read more
S1701 - A Randomized Phase II Trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Read more
NRG-LU005 - LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE II/III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB
Read more
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous NonSmall Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature driven Analysis
Read more
Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Read more
Alliance A081105 - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Read more
ECOG E4512 - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Read more

DISEASES & CONDITIONS TREATED

All Cancers and Hematological Conditions
Lung Cancer
Mesothelioma

TREATMENTS / SERVICES

Apheresis
Blood Transfusion
Bone Marrow Aspiration
Bone Marrow Biopsy
Bone Marrow Transplantation (BMT)
Chemotherapy
Clinical Trials
Conscious Sedation
Infusional Therapies
Lumbar Puncture
Paracentesis
Stem Cell Collection Procedures
Stem Cell Transplantation
Thoracentesis

CLINICAL LOCATIONS

Upstate Cancer Center
750 East Adams Street
Syracuse, NY 13210
315-464-8200
Upstate University Hospital
750 East Adams Street
Syracuse, NY 13210
315-464-5540
Upstate Cancer Center
750 East Adams Street
Syracuse, NY 13210
315-464-8200
603 Seneca Street
603 Seneca Street
Oneida, NY 13421
315-361-1041

CLINICAL SECTION AFFILIATIONS

Medicine
Hematology and Oncology
Upstate Cancer Center
Medical Oncology

CURRENT HOSPITAL PRIVILEGES

Upstate University Hospital

CAMPUSES

Downtown